Correspondence to Dr Onno W Akkerman; [email protected]
Strengths and limitations of this study
PubMed, CINAHL and EMBASE were systematically searched for studies in the last decade, to prevent older studies describing outdated supportive care strategies to be eligible for inclusion.
As there is no instrument for ‘risk of bias assessment’ of studies on diagnosis (eg, malnutrition assessment), we evaluated risk of bias by scoring the presence of essential components required for adequate assessment and reporting of malnutrition.
To report on how malnutrition was assessed in studies on tuberculosis (TB), we quantified how malnutrition assessment methods capture the international consensus definition for malnutrition, in patients with TB.
Implementation of new criteria in study protocols takes time. This implementation might take longer than the time period used in this review.
Background
In 2019, tuberculosis (TB) was the worldwide leading cause of death from a single infectious agent, with 10 million new patients, and 1.2 million deaths.1 TB prevalence is up to 20 times higher among people living in low-income countries compared with high-income countries.2 TB, poverty and malnutrition are closely linked. Prevalence of malnutrition in patients with TB is studied to be 50% to 57%, and malnutrition is associated with a twofold risk of dying.3–9
As hunger-related malnutrition caused by food-insecurity impacts the immune system,1 10 11 malnutrition is an important risk factor for re-activation of TB, with a reported 27% attributable risk.1 12 Malnutrition is considered an important, potentially reversible risk factor for treatment failure.13 Therefore, a better understanding in assessing malnutrition in patients with TB is urgently needed.14
The European Society for Clinical Nutrition and Metabolism (ESPEN) defines malnutrition as ‘a state resulting from lack of intake or uptake of nutrition that leads to altered body composition (decreased fat-free mass) and body cell mass leading to diminished physical and mental function and impaired clinical outcome from disease’.10 In patients with TB, two types of malnutrition may coexist: malnutrition without disease10; and disease-related malnutrition once active disease has developed. The latter is often driven by a combination of loss of appetite, malabsorption and/or inflammation-driven catabolism.10 11 A low body mass index (BMI) is a characteristic for chronic malnutrition.15 However, since malnutrition leads to loss of fat-free mass in all individuals, including those who are overweight or obese, patients with either a normal or high BMI may be malnourished as well.10 In 2015, ESPEN published their first consensus on diagnostic criteria for malnutrition,15 followed by the Global Leadership Initiative on Malnutrition (GLIM) criteria in 2018, which were established by ESPEN, the American Society for Parenteral and Enteral Nutrition, la Federación Latino Americano de Terapia Nutriconal, Nutricion Clinica y Metabolismo and the Parenteral and Enteral Nutrition Society of Asia.16
It was not until 2013 that the WHO presented their first guideline on nutritional care and support for patients with TB. In this guideline, the WHO stressed that all patients with active TB receive individualised nutritional assessment and management, including dietary counselling and nutritional interventions, to improve nutritional status and consequently, prevent TB treatment failure.17 Nutritional assessment is a necessary step in the ‘nutritional care process’, enabling the professional to design a treatment plan together with the patient.18 However, the 2013 WHO guideline only refers to BMI as a method of assessing malnutrition for adults. The important issue of lack of consistency and understanding of how malnutrition can be assessed in patients with TB results from, the complexity of TB being on the one hand strongly associated with malnutrition and on the other by the vertical and siloed nature of TB programmes.
The primary aim of this review is to identify malnutrition assessment methods that are used in adult patients with TB. The secondary aim is to quantify how malnutrition assessment methods capture the international consensus definition for malnutrition in this population.
Methods
The protocol for this review was registered at PROSPERO with number CRD42019122832. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was used.19
Search strategy
In September 2020, PubMed, CINAHL and EMBASE were systematically searched for studies in any language. The search term consisted of a domain describing ‘malnutrition’ and a domain describing ‘tuberculosis’, while excluding in vitro, animal and paediatric studies. Details of the search strategy can be found in online supplemental material 1.
Inclusion and exclusion criteria
Studies in the English language that aimed to assess malnutrition and described a method for assessment of malnutrition in patients with microbiologically confirmed or clinically diagnosed TB, published between 1 January 2009 and 18 September 2020 were considered eligible for inclusion. Since the aim of the review is to identify how malnutrition is assessed in current research, 2009 was chosen as a starting point. Restricting the search to the last decade will prevent older studies describing outdated supportive care strategies to be eligible for inclusion.
Only studies that focused on adult patients with TB were included, because the assessment of malnutrition in children requires different methods than in adults as children are growing, and the criteria for measuring their nutritional status differ per by age.20
Reviews and study protocols were excluded since they do not present original data. Case reports and abstracts/posters were also excluded since the information provided on methods used in this type of publication is considered too limited.
Study selection
Screening of title and abstract was done independently by two authors using the Rayyan web application.21 Evaluation of the screening of the first 10 articles was used to define the criteria that determine which studies were eligible for final inclusion. Final inclusion was based on an independent judgement of the full text of both authors. Disagreements about inclusion were resolved through discussion and if consensus was not reached, a third author was consulted, which resulted in consensus in all cases.
Patient and public involvement
No patient involved
Data collection
Data collection was performed by two authors independently. The following characteristics were extracted from each study: citation, first author, country, years of publication and data collection, aim of the malnutrition assessment, number of included patients, number of HIV coinfected patients, disease location, drug susceptibility of the Mycobacterium tuberculosis isolate.
Data analysis
To report on how malnutrition was assessed in studies on TB, we determined the extent of capturing of the three domains of malnutrition, malnutrition included in the ESPEN conceptual definition of malnutrition, that is, intake or uptake of nutrition (Domain A), body composition (Domain B), and physical and cognitive function (Domain C).10 22 23
Domain A was considered to be covered to some extent (+) if the method addressed nutritional intake or uptake at all. It was considered to be covered extensively (++) if the method addressed nutritional intake or uptake in depth. For domain B, weight change, BMI and anthropometric measurements, such as skinfold measurements were considered covering domain B to some extent (+). It was considered extensively addressed (++) if the method included identification of muscle mass, lean mass or fat-free mass. Domain C was considered to be covered to some extent (+) if functionality was addressed. Domain C was considered extensively covered (++) if physical (eg, handgrip strength), mental and cognitive function tests were performed, or questions about activities of daily living were addressed.
As micronutrient or trace elements in serum are not representative for intake or uptake of protein or energy,10 laboratory tests were not considered to attribute to any of the malnutrition domains. Serum albumin and C reactive protein are parameters for inflammation but are not related to parameters of protein/energy intake or functionality, nor do they represent body composition and were therefore not taken into consideration. In addition, while prealbumin (ie, transthyretin) is sensitive for changes in protein and energy intake, this marker is influenced by inflammation activity.10
As there is no instrument for ‘risk of bias assessment’ of studies on diagnosis (eg, malnutrition assessment), we evaluated risk of bias by scoring the presence of essential components required for adequate assessment and reporting of malnutrition. The risk of bias in included studies was assessed by rating the following four characteristics:
Rationale for the assessment of malnutrition.
Malnutrition was assessed and clear cut-off points were described in the method section. For example: 'malnutrition was assessed as BMI <18.5 kg/m2.
Malnutrition was reported in the results section.
The results with regard to malnutrition were reflected on in the discussion section.
The characteristics were graded for quality of the study. Risk of bias was rated by - (meaning high risk of bias), + (medium risk of bias), or ++ (low risk of bias). The scores were added and the total was translated into very low (≥7 plusses), low (5–6 plusses), medium (3–4 plusses) or high risk of bias (≤2 plusses).
Results
The search resulted in 2175 studies after removal of duplicates. After screening by title and abstract, 272 studies were selected for a full text eligibility check. Review of the full text resulted in inclusion of 69 studies.3 24–91 A flow diagram of the selection process is visualised in figure 1.
Figure 1. Flow diagram of the selection process of studies describing assessment in the context of malnutrition.
In total, among 69 studies, 17 different methods were used to assess malnutrition. Four studies used multiple (ie, two to four) methods to assess malnutrition. Four studies used multiple criteria but integrated these together into one method to perform an assessment. In 53/69 (77%) of the studies, BMI was used as single assessment method. Among these studies eight different cut-off points were used, 34/53 studies (64%) used BMI <18.5 kg/m2. In seven studies, no cut-off values for BMI were described. Table 1 shows all the cut-off values of BMI used as single method.
Table 1Cut-off values BMI exclusively used
Cut-off value | Studies using only BMI for assessment of malnutrition n=53 |
≤20.0 kg/m2 | 1 |
<20.0 kg/m2 | 2 |
<18.5 kg/m2 | 34 |
≤18.5 kg/m2 | 3 |
<18.49 kg/m2 | 1 |
<18.4 kg/m2 | 1 |
<17.0 kg/m2 | 2 |
<16.0 kg/m2 | 2 |
No clear cut-off value described in study | 7 |
BMI, body mass index.
Capturing of the domains of malnutrition
Table 2 presents the capturing of the domains of malnutrition per assessment method.3 24–91 Uptake or intake of nutrition (A) was addressed to some extent by four methods that were used in five of the 69 studies. Body composition (B) was addressed to some extent by all but two studies, 67/69 (97%). Two methods did not address domain B, as these were methods that used self-reporting of diet quality and a food frequency questionnaire as assessment methods. Physical and/or cognitive functionality (C) was addressed to some extent by only 3/69 studies (4%).
Table 2Comparison of 17 different assessment methods by malnutrition domain capturing
Domains | A | B | C | Total |
Description of domain | Intake or uptake of nutrition | Body composition | Physical and cognitive function | |
PIBW, BMI, albumin, TLC, cholesterol, Hb | – | + | – | + |
Weight change | – | + | – | + |
BMI & MUAC | – | + | – | + |
Self-report of diet quality | + | – | – | + |
MNA | ++ | + | ++ | +++++ |
MUST | + | + | – | ++ |
AMA | – | ++ | – | ++ |
BMI/albumin | – | + | – | + |
BMI, MUAC, TSF, MAMC, Hb, Ht, albumin, total protein, globulin, iron fixation capacity, retinol, tocopherol Zn, SE, Fe | – | + | – | + |
MAMC | – | ++ | – | ++ |
Underweight | – | + | – | + |
TSF/TST | – | + | – | + |
SGA | ++ | ++ | ++ | ++++++ |
BMI | – | + | – | + |
BIA: (body fat%) | – | + | – | + |
MUAC | – | + | – | + |
FFQ | ++ | – | – | ++ |
AMA, arm muscle area; BIA, bio-electrical impedance analysis; BMI, body mass index; Fe, iron; FFQ, Food Frequency Questionnaire; Hb, haemoglobin; Ht, haematocrit; MAMC, mid arm muscle circumference; MNA, mini nutritional assessment; MUAC, mid upper arm circumference; PIBW, percent ideal body weight; SE, selenium; SGA, subjective global assessment; TLC, total lymphocyte count; TSF, triceps skin fold ; TST, triceps skinfold thickness; Zn, zinc.
Only 2 of the 17 different assessment methods that were used in the 69 studies captured all three domains of the definition, that is, the Subjective Global Assessment was used in two studies and the Mini Nutritional Assessment was used in one study. Forty-one studies (59%) assessed malnutrition for the purpose of their primary aim. The three studies that used a method that captured all three domains of the definition, had a primary aim related to malnutrition.
A descriptive subanalysis, as shown in table 3, was performed to compare studies regarding their use of assessment tools, by their period of data collection.3 24–91 No differences were found between 5-year periods regarding the use of BMI as the only assessment method. The studies that used methods that capture all three domains of the ESPEN definition of malnutrition did not describe when their data was collected Of the 69 included studies, 18 studies (26%) were on inpatients, 26 studies (38%) on outpatients, 7 (10%) on both type of patients and in 18 studies (26%) the type of patients was not described.
Table 3Subanalysis of malnutrition assessment methods
Year of start data collection | No of studies (n=69) | BMI as the only assessment method N % | Use of an assessment method that attributes to three domains % |
2000–2004 | 9 | 9 89 | – |
2005–2009 | 12 | 7 58 | – |
2010–2014 | 14 | 13 93 | – |
2015–2019 | 19 | 15 79 | – |
No available data on year of data collection | 15 | 10 67 | 3 20 |
Total | 69 | 53 77 | 3 4 |
Risk of bias assessment
Online supplemental material 2 shows the risk of bias assessment and details of the 69 included studies.3 24–91 Twenty-one of the 69 studies (30%) did not describe the rationale for the assessment of malnutrition. Fifteen of the 69 studies (22%) described their assessment method without clear cut-off values. Risk of bias was very low in 24 studies (35%), low in 20 studies (29%), medium in 20 studies (29%) and high in five studies (7%).
Discussion
This review showed that most patients with TB are assessed for only one aspects of the construct of malnutrition. BMI is often used assessment method for malnutrition in studies with patients with TB, even though it only partly covers just one malnutrition domain (domain B). In addition, while some studies did not report a cut-off value for BMI, in other studies different cut-off values for BMI were used, therefore making it difficult to compare these studies. The use of BMI could be justified from a public health perspective, since a low BMI is a characteristic of chronic malnutrition that involves loss of both fat and muscle tissue.15 However, the use of BMI alone for assessing malnutrition in this population is debatable. In clinical settings, disease-related malnutrition is the predominant type of malnutrition. Disease-related malnutrition is a (sub)acute condition, in which loss of weight and muscle/fat-free mass does not automatically result in a low BMI, while loss of weight and fat-free mass are related to poor clinical outcomes including increased morbidity and mortality.15 92 With the current global overweight and obesity epidemic, patients with catabolic diseases such as TB may lose more than 20% of their weight and muscle mass within 3–6 months, and still show BMI values at or above normal range.93 When assessing malnutrition in patients with TB solely based on BMI, these patients will not be identified when they are malnourished, despite the therapeutic and prognostic implications of malnutrition.94
This review indicates that the international criteria for the assessment of malnutrition have not yet found their way into studies with patients with TB. The 2013 WHO guideline on nutritional care only refers to BMI as a method of assessing malnutrition for adults, which may contribute to the status quo. BMI is by far the most frequently used assessment method for malnutrition (77%) in studies with patients with TB. Only a few (4%) of the studies that reported on the assessment methods addressed all domains of the conceptual definition of malnutrition. For the studies performed after the ESPEN criteria of 201595 and the GLIM criteria of 2018,16 this may be explained by the fact that the WHO does not yet refer to these criteria in their communications. The GLIM criteria have been developed for global use and is therefore recommended to be used in any setting for all patients with TB. The GLIM framework does not include the domain of functionality as criterion.
There are some limitations in our study. First, our study focused on published articles and not on the underlying study protocol. In some cases, detailed information on the assessment and operationalisation of malnutrition might be available in the study protocol, however, it was not addressed in the article making it unavailable to the public domain. Second, implementation of new criteria in study protocols takes time. This implementation might take longer than the time period used in this review. Third: research and clinical practice are different settings and the results from our review are not a reflection of clinical practice. Nevertheless, we postulate that BMI is used the most commonly used method in clinical practice since the WHO recommends that BMI is the method to assess undernutrition/malnutrition.
Awareness of the presence of malnutrition and concept of malnutrition assessment in healthcare professionals working with patients with TB needs improvement. Future studies regarding malnutrition assessment in patients with TB should aim at implementation of international consensus criteria regarding malnutrition assessment. Using the same terminology for malnutrition may make a difference to our patients, improve outcomes as well as reduce chronic sequelae and help to end TB.
It should be stressed that we need to agree on using standardised methods for malnutrition assessment and interventions. However, malnutrition assessment should always be preceded by malnutrition screening with a validated tool (online supplemental material 3).16
In conclusion, most studies in adult patients with TB did not describe their assessment method for malnutrition. Most patients with TB are assessed for only one or two aspects of the conceptual definition of malnutrition. Various methods for assessing of malnutrition have been used, and only a very small proportion of the published studies on TB used an assessment method that fully reflects the definition of malnutrition. The use of international consensus criteria is recommended to establish systematic and uniform diagnostics and treatment of malnutrition.
We thank Martine Sealy for her contribution to the conceptualisation and visualisation of this review.We thank Giovanni Sotgiu for his feedback on the manuscript. We thank the Central Medical Library of the University of Groningen for their help with designing our search strategy.
Data availability statement
No data are available. No additional data available.
Ethics statements
Patient consent for publication
Not applicable.
Ethics approval
This study does not involve human participants.
LtB and MSB contributed equally.
Contributors LtB: conception and design, data collection, acquisition, analysis, interpretation of data; drafting. MB: conception and design, data collection, acquisition, analysis, interpretation of data; revising draft critically for important intellectual content. HJ-W: interpretation of data and revising draft critically for important intellectual content. RB: acquisition, analysis, interpretation of data; drafting. MGGS: interpretation of data, and revising draft critically for important intellectual content. HAMK: interpretation of data, and revising draft critically for important intellectual content. WdL: interpretation of data, and revising draft critically for important intellectual content. ST: interpretation of data, and revising draft critically for important intellectual content. TSvdW: interpretation of data, and revising draft critically for important intellectual content. J-WCA: interpretation of data, and revising draft critically for important intellectual content. OWA: conception and design, interpretation of data; revising draft critically for important intellectual content. OWA is responsible for the overall content as guarantor.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests HJ-W was codeveloper of the Patient-Generated Subjective Global Assessment©-based Pt-Global© app/web tool.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
1 World Health Organisation. Global tuberculosis report. Geneva, 2020.
2 World Health Organization. Addressing poverty in TB control - options for national TB control programmes. Geneva, 2005.
3 Bhargava A, Chatterjee M, Jain Y, et al. Nutritional status of adult patients with pulmonary tuberculosis in rural central India and its association with mortality. PLoS One 2013; 8: e77979. doi:10.1371/journal.pone.0077979 http://www.ncbi.nlm.nih.gov/pubmed/24205052
4 Nthiga I, David-Kigaru D, Mugendi J. The nutritional status of pulmonary tuberculosis patients aged 25-44 years attending tuberculosis clinic at Lodwar County and referral Hospital, Turkana County, Kenya 2017; 2: 2455–4898.
5 Wondmieneh A, Gedefaw G, Getie A, et al. Prevalence of undernutrition among adult tuberculosis patients in Ethiopia: A systematic review and meta-analysis. J Clin Tuberc Other Mycobact Dis 2021; 22: 100211. doi:10.1016/j.jctube.2020.100211 http://www.ncbi.nlm.nih.gov/pubmed/33458257
6 Zachariah R, Spielmann MP, Harries AD, et al. Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans R Soc Trop Med Hyg 2002; 96: 291–4. doi:10.1016/s0035-9203(02)90103-3 http://www.ncbi.nlm.nih.gov/pubmed/12174782
7 Dodor E. Evaluation of nutritional status of new tuberculosis patients at the effia-nkwanta regional hospital. Ghana Med J 2008; 42: 22–8. http://www.ncbi.nlm.nih.gov/pubmed/18560556
8 Subedi S, Mehta R, Parajuli P. Nutritional status of patients with pulmonary tuberculosis receiving anti-tuberculosis treatment at BP Koirala Institute of health sciences, Nepal 2019.
9 Bhargava A, Benedetti A, Oxlade O, et al. Undernutrition and the incidence of tuberculosis in India: national and subnational estimates of the population-attributable fraction related to undernutrition. Natl Med J India 2014; 27: 128–33. http://www.ncbi.nlm.nih.gov/pubmed/25668081
10 Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 2017; 36: 49–64. doi:10.1016/j.clnu.2016.09.004 http://www.ncbi.nlm.nih.gov/pubmed/27642056
11 Sobotka L, Allison SP, Forbes A. Basics in clinical nutrition. Prague, Czech Republic: Publishing House Galen, 2011.
12 Dheda K, Barry CE, Maartens G. Tuberculosis. Lancet 2016; 387: 1211–26. doi:10.1016/S0140-6736(15)00151-8 http://www.ncbi.nlm.nih.gov/pubmed/26377143
13 Choi R, Jeong BH, Koh WJ, et al. Recommendations for optimizing tuberculosis treatment: therapeutic drug monitoring, pharmacogenetics, and nutritional status considerations. Ann Lab Med 2017; 37: 97–107. doi:10.3343/alm.2017.37.2.97 http://www.ncbi.nlm.nih.gov/pubmed/28028995
14 World Health Organization. The end TB strategy. Geneva, 2014.
15 Cederholm T, Bosaeus I, Barazzoni R. Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr 2015; 34: 335–40.
16 Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle 2019; 10: 207–17. doi:10.1002/jcsm.12383 http://www.ncbi.nlm.nih.gov/pubmed/30920778
17 World Health Organisation. Nutritional care and support for patients with tuberculosis. Geneva, 2013.
18 Lacey K, Pritchett E. Nutrition care process and model: ADA adopts road map to quality care and outcomes management. J Am Diet Assoc 2003; 103: 1061–72. doi:10.1016/s0002-8223(03)00971-4 http://www.ncbi.nlm.nih.gov/pubmed/12891159
19 Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097. doi:10.1371/journal.pmed.1000097 http://www.ncbi.nlm.nih.gov/pubmed/19621072
20 Turck D, Braegger CP, Colombo C, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr 2016; 35: 557–77. doi:10.1016/j.clnu.2016.03.004 http://www.ncbi.nlm.nih.gov/pubmed/27068495
21 Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016; 5: 210. doi:10.1186/s13643-016-0384-4 http://www.ncbi.nlm.nih.gov/pubmed/27919275
22 Ter Beek L, Vanhauwaert E, Slinde F, et al. Unsatisfactory knowledge and use of terminology regarding malnutrition, starvation, cachexia and sarcopenia among dietitians. Clin Nutr 2016; 35: 1450–6. doi:10.1016/j.clnu.2016.03.023 http://www.ncbi.nlm.nih.gov/pubmed/27075318
23 Sealy MJ, Nijholt W, Stuiver MM, et al. Content validity across methods of malnutrition assessment in patients with cancer is limited. J Clin Epidemiol 2016; 76: 125–36. doi:10.1016/j.jclinepi.2016.02.020 http://www.ncbi.nlm.nih.gov/pubmed/26931291
24 Mollah A, Shrivastava P, Das DK, et al. Nutritional status of adult tuberculosis patients in Burdwan municipality area of West Bengal. Indian J Community Health 2020; 32: 438–43. doi:10.47203/IJCH.2020.v32i02.024
25 White LV, Edwards T, Lee N, et al. Patterns and predictors of co-morbidities in tuberculosis: a cross-sectional study in the Philippines. Sci Rep 2020; 10: 4100. doi:10.1038/s41598-020-60942-2 http://www.ncbi.nlm.nih.gov/pubmed/32139742
26 Edwards T, White LV, Lee N, et al. Effects of comorbidities on quality of life in Filipino people with tuberculosis. Int J Tuberc Lung Dis 2020; 24: 712–9. doi:10.5588/ijtld.19.0734 http://www.ncbi.nlm.nih.gov/pubmed/32718405
27 Seid G, Ayele M. Undernutrition and mortality among adult tuberculosis patients in Addis Ababa, Ethiopia. Adv Prev Med 2020; 2020: 5238010. doi:10.1155/2020/5238010 http://www.ncbi.nlm.nih.gov/pubmed/32802521
28 Musuenge BB, Poda GG, Chen P-C. Nutritional status of patients with tuberculosis and associated factors in the health centre region of Burkina Faso. Nutrients 2020; 12. doi: doi:10.3390/nu12092540. [Epub ahead of print: 21 Aug 2020 ]. http://www.ncbi.nlm.nih.gov/pubmed/32825756
29 Ma'rufi I, Ali K, Jati SK, et al. Improvement of Nutritional Status among Tuberculosis Patients by Channa striata Supplementation: A True Experimental Study in Indonesia. Biomed Res Int 2020; 2020: 1–10. doi:10.1155/2020/7491702 http://www.ncbi.nlm.nih.gov/pubmed/32420367
30 White LV, Edwards T, Lee N. Co-morbidities in Filipino persons with tuberculosis: a cross-sectional study in urban and rural public TBDOTS facilities. Trans R Soc Trop Med Hyg 2019; 113: S210.
31 Wessels J, Walsh CM, Nel M. Smoking habits and alcohol use of patients with tuberculosis at Standerton tuberculosis specialised Hospital, Mpumalanga, South Africa. Health SA 2019; 24: 1146. doi:10.4102/hsag.v24i0.1146 http://www.ncbi.nlm.nih.gov/pubmed/31934425
32 Wardani DWSR, Wahono EP. Predominant determinants of delayed tuberculosis sputum conversion in Indonesia. Indian J Community Med 2019; 44: 53–7. doi:10.4103/ijcm.IJCM_319_18 http://www.ncbi.nlm.nih.gov/pubmed/30983715
33 Ren Z, Zhao F, Chen H, et al. Nutritional intakes and associated factors among tuberculosis patients: a cross-sectional study in China. BMC Infect Dis 2019; 19: 907. doi:10.1186/s12879-019-4481-6 http://www.ncbi.nlm.nih.gov/pubmed/31664922
34 Rashak HA, Sánchez-Pérez HJ, Abdelbary BE, et al. Diabetes, undernutrition, migration and Indigenous communities: tuberculosis in Chiapas, Mexico. Epidemiol Infect 2019; 147: e71. doi:10.1017/S0950268818003461 http://www.ncbi.nlm.nih.gov/pubmed/30869023
35 Mailu EW, Owiti P, Ade S, et al. Tuberculosis control activities in the private and public health sectors of Kenya from 2013 to 2017: how do they compare? Trans R Soc Trop Med Hyg 2019; 113: 740–8. doi:10.1093/trstmh/trz062 http://www.ncbi.nlm.nih.gov/pubmed/31334760
36 Lee N, White LV, Marin FP, et al. Mid-upper arm circumference predicts death in adult patients admitted to a TB ward in the Philippines: a prospective cohort study. PLoS One 2019; 14: e0218193. doi:10.1371/journal.pone.0218193 http://www.ncbi.nlm.nih.gov/pubmed/31246958
37 Hussien B, Hussen MM, Seid A, et al. Nutritional deficiency and associated factors among new pulmonary tuberculosis patients of bale zone hospitals, Southeast Ethiopia. BMC Res Notes 2019; 12: 751. doi:10.1186/s13104-019-4786-y http://www.ncbi.nlm.nih.gov/pubmed/31744538
38 Hoyt KJ, Sarkar S, White L, et al. Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis. PLoS One 2019; 14: e0214011. doi:10.1371/journal.pone.0214011 http://www.ncbi.nlm.nih.gov/pubmed/30917170
39 Gashaw F, Bekele S, Mekonnen Y, et al. High helminthic co-infection in tuberculosis patients with undernutritional status in northeastern Ethiopia. Infect Dis Poverty 2019; 8: 88. doi:10.1186/s40249-019-0600-2 http://www.ncbi.nlm.nih.gov/pubmed/31623676
40 Feleke BE, Feleke TE, Biadglegne F. Nutritional status of tuberculosis patients, a comparative cross-sectional study. BMC Pulm Med 2019; 19: 182. doi:10.1186/s12890-019-0953-0 http://www.ncbi.nlm.nih.gov/pubmed/31638950
41 da Silva LF, Skupien EC, Lazzari TK, et al. Advanced glycation end products (age) and receptor for age (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status. PLoS One 2019; 14: e0213991. doi:10.1371/journal.pone.0213991 http://www.ncbi.nlm.nih.gov/pubmed/30870511
42 Chebrolu P, Laux T, Chowdhury S, et al. The risk of refeeding syndrome among severely malnourished tuberculosis patients in Chhattisgarh, India. Indian J Tuberc 2020; 67: 152–8. doi:10.1016/j.ijtb.2019.03.004 http://www.ncbi.nlm.nih.gov/pubmed/32553304
43 Benzekri NA, Sambou JF, Tamba IT, et al. Nutrition support for HIV-TB co-infected adults in Senegal, West Africa: a randomized pilot implementation study. PLoS One 2019; 14: e0219118. doi:10.1371/journal.pone.0219118 http://www.ncbi.nlm.nih.gov/pubmed/31318879
44 Abdullahi OA, Ngari MM, Sanga D, et al. Mortality during treatment for tuberculosis; a review of surveillance data in a rural County in Kenya. PLoS One 2019; 14: e0219191. doi:10.1371/journal.pone.0219191 http://www.ncbi.nlm.nih.gov/pubmed/31295277
45 Skupien EC, Lazzari TK, Coutinho SE, et al. The relation between leptin and inflammatory markers with respiratory and peripheral muscle strength in tuberculosis: a case-control study. Clin Respir J 2018; 12: 2559–65. doi:10.1111/crj.12956 http://www.ncbi.nlm.nih.gov/pubmed/30180300
46 Cheng W, Zhang S, Li Y, et al. Intestinal tuberculosis: clinico-pathological profile and the importance of a high degree of suspicion. Trop Med Int Health 2019; 24: 81–90. doi:10.1111/tmi.13169 http://www.ncbi.nlm.nih.gov/pubmed/30338607
47 Lazzari TK, Forte GC, Silva DR. Nutrition status among HIV-positive and HIV-negative inpatients with pulmonary tuberculosis. Nutr Clin Pract 2018; 33: 858–64. doi:10.1002/ncp.10006 http://www.ncbi.nlm.nih.gov/pubmed/29397039
48 Sattler FR, Chelliah D, Wu X, et al. Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD 4 Cells. Pathog Immun 2018; 3: 46–62. doi:10.20411/pai.v3i1.235 http://www.ncbi.nlm.nih.gov/pubmed/29770360
49 Rao VG, Bhat J, Yadav R, et al. A comparative study of the socio-economic risk factors for pulmonary tuberculosis in the Saharia tribe of Madhya Pradesh, India. Trans R Soc Trop Med Hyg 2018; 112: 272–8. doi:10.1093/trstmh/try052 http://www.ncbi.nlm.nih.gov/pubmed/29931208
50 Pande T, Huddart S, Xavier W, et al. Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: a descriptive analysis. PLoS One 2018; 13: e0200838. doi:10.1371/journal.pone.0200838 http://www.ncbi.nlm.nih.gov/pubmed/30021016
51 Gurung LM, Bhatt LD, Karmacharya I, et al. Dietary practice and nutritional status of tuberculosis patients in Pokhara: a cross sectional study. Front Nutr 2018; 5: 1–6. doi:10.3389/fnut.2018.00063
52 Piparva KG, Jansari G, Singh AP. Evaluation of treatment outcome and adverse drug reaction of directly observed treatment (DOT) plus regimen in multidrug-resistant tuberculosis (MDR-TB) patients at district tuberculosis centre Rajkot. Perspect Clin Res 2018; 9: 165–9. doi:10.4103/picr.PICR_165_17 http://www.ncbi.nlm.nih.gov/pubmed/30319946
53 Hochberg NS, Sarkar S, Horsburgh CR, et al. Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: opportunities for intervention. PLoS One 2017; 12: e0183195. doi:10.1371/journal.pone.0183195 http://www.ncbi.nlm.nih.gov/pubmed/28832615
54 Bhat J, Rao VG, Sharma RK, et al. Investigation of the risk factors for pulmonary tuberculosis: A case-control study among Saharia tribe in Gwalior district, Madhya Pradesh, India. Indian J Med Res 2017; 146: 97–104. doi:10.4103/ijmr.IJMR_1029_16 http://www.ncbi.nlm.nih.gov/pubmed/29168465
55 Abdelbary BE, Garcia-Viveros M, Ramirez-Oropesa H, et al. Predicting treatment failure, death and drug resistance using a computed risk score among newly diagnosed TB patients in Tamaulipas, Mexico. Epidemiol Infect 2017; 145: 3020–34. doi:10.1017/S0950268817001911 http://www.ncbi.nlm.nih.gov/pubmed/28903800
56 Pandit A, Kumar Pandey A, Department of Medicine, Index Medical College, Indore, M.P., India. Liver dysfunction in pulmonary tuberculosis patients on dots: a study and review. J Gastroenterol Hepatol Res 2016; 5: 2254–60. doi:10.17554/j.issn.2224-3992.2016.05.670
57 Buntoro IF, Kristin E S. Decrease of liver function after treatment of antituberculosis drugs in tuberculosis patients with malnutrition and alcohol consumption. Int J Pharm Pharm Sci 2016; 8: 269–73.
58 Araújo-Mariz C, Lopes EP, Acioli-Santos B, et al. Hepatotoxicity during treatment for tuberculosis in people living with HIV/AIDS. PLoS One 2016; 11: e0157725. doi:10.1371/journal.pone.0157725 http://www.ncbi.nlm.nih.gov/pubmed/27332812
59 Gebrecherkos T, Gelaw B, Tessema B. Smear positive pulmonary tuberculosis and HIV co-infection in prison settings of North Gondar zone, Northwest Ethiopia. BMC Public Health 2016; 16: 1091. doi:10.1186/s12889-016-3761-y http://www.ncbi.nlm.nih.gov/pubmed/27756279
60 McLachlan I, Visser WI, Jordaan HF. Skin conditions in a South African tuberculosis Hospital: prevalence, description, and possible associations. Int J Dermatol 2016; 55: 1234–41. doi:10.1111/ijd.13355 http://www.ncbi.nlm.nih.gov/pubmed/27419379
61 Ezeamama AE, Mupere E, Oloya J, et al. Age, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapy. Int J Infect Dis 2015; 35: 73–9. doi:10.1016/j.ijid.2015.04.008 http://www.ncbi.nlm.nih.gov/pubmed/25910854
62 Medellín-Garibay SE, Cortez-Espinosa N, Milán-Segovia RC, et al. Clinical pharmacokinetics of rifampin in patients with tuberculosis and type 2 diabetes mellitus: association with biochemical and immunological parameters. Antimicrob Agents Chemother 2015; 59: 7707–14. doi:10.1128/AAC.01067-15 http://www.ncbi.nlm.nih.gov/pubmed/26438503
63 Te Brake LH, Ruslami R, Later-Nijland H. Exposure to total and protein-unbound rifampicin is not affected by malnutrition in Indonesian tuberculosis patients. Antimicrob Agents Chemother 2015; 74: 986–90.
64 Golemba AS, Ferreyra FGE, Martearena RE, et al. Drug-induced hepatotoxicity and tuberculosis in a hospital from the Argentinian northeast: cross-sectional study. Medwave 2015; 15: e6135. doi:10.5867/medwave.2015.04.6135 http://www.ncbi.nlm.nih.gov/pubmed/26035138
65 Bacelo AC, Ramalho A, Brasil PE, et al. Nutritional supplementation is a necessary complement to dietary counseling among tuberculosis and Tuberculosis-HIV patients. PLoS One 2015; 10: e0134785. doi:10.1371/journal.pone.0134785 http://www.ncbi.nlm.nih.gov/pubmed/26313258
66 Kumar NSS, Hemraj SK, Dutt RA. Phase angle measurement in pulmonary tuberculosis patients and control subjects using bio-impedance analysis. Indian J Tuberc 2014; 61: 224–31. http://www.ncbi.nlm.nih.gov/pubmed/25241571
67 Tian P-W, Wang Y, Shen Y-C, et al. Different risk factors of recurrent pulmonary tuberculosis between Tibetan and Han populations in Southwest China. Eur Rev Med Pharmacol Sci 2014; 18: 1482–6. http://www.ncbi.nlm.nih.gov/pubmed/24899606
68 Oliveira MG, Delogo KN, Oliveira HMdeMGde, et al. Anemia in hospitalized patients with pulmonary tuberculosis. J Bras Pneumol 2014; 40: 403–10. doi:10.1590/S1806-37132014000400008 http://www.ncbi.nlm.nih.gov/pubmed/25210963
69 Maeda S, Hang NTL, Lien LT, et al. Mycobacterium tuberculosis strains spreading in Hanoi, Vietnam: Beijing sublineages, genotypes, drug susceptibility patterns, and host factors. Tuberculosis 2014; 94: 649–56. doi:10.1016/j.tube.2014.09.005 http://www.ncbi.nlm.nih.gov/pubmed/25459163
70 Miyata S, Tanaka M, Ihaku D. The prognostic significance of nutritional status using malnutrition universal screening tool in patients with pulmonary tuberculosis. Nutr J 2013; 12: 42. doi:10.1186/1475-2891-12-42 http://www.ncbi.nlm.nih.gov/pubmed/23565890
71 R I, Bambang W, Priatna DY. The effect of zinc, lysine and vitamin A supplementation to increase cellular immune response of pulmonary tuberculosis patients. J Trace Elem Med Biol 2013; 27: 21.
72 Bakari M, Wamsele J, MacKenzie T, et al. Nutritional status of HIV-infected women with tuberculosis in Dar es Salaam, Tanzania. Public Health Action 2013; 3: 224–9. doi:10.5588/pha.13.0028 http://www.ncbi.nlm.nih.gov/pubmed/26393034
73 Miyata S, Tanaka M, Ihaku D. Full mini nutritional assessment and prognosis in elderly patients with pulmonary tuberculosis. J Am Coll Nutr 2013; 32: 307–11. doi:10.1080/07315724.2013.826114 http://www.ncbi.nlm.nih.gov/pubmed/24219373
74 Chittoor G, Arya R, Farook VS, et al. Epidemiologic investigation of tuberculosis in a Mexican population from Chihuahua state, Mexico: a pilot study. Tuberculosis 2013; 93(Suppl): S71–7. doi:10.1016/S1472-9792(13)70014-3 http://www.ncbi.nlm.nih.gov/pubmed/24388653
75 Islam QS, Ahmed SM, Islam MA, et al. Beyond drugs: tuberculosis patients in Bangladesh need nutritional support during convalescence. Public Health Action 2013; 3: 136–40. doi:10.5588/pha.13.0005 http://www.ncbi.nlm.nih.gov/pubmed/26393016
76 Piva SGN, Costa MdaCN, Barreto FR, et al. Prevalence of nutritional deficiency in patients with pulmonary tuberculosis. J Bras Pneumol 2013; 39: 476–83. doi:10.1590/S1806-37132013000400012 http://www.ncbi.nlm.nih.gov/pubmed/24068270
77 Mupere E, Malone L, Zalwango S, et al. Lean tissue mass wasting is associated with increased risk of mortality among women with pulmonary tuberculosis in urban Uganda. Ann Epidemiol 2012; 22: 466–73. doi:10.1016/j.annepidem.2012.04.007 http://www.ncbi.nlm.nih.gov/pubmed/22575813
78 Miyata S, Tanaka M, Ihaku D. Subjective global assessment in patients with pulmonary tuberculosis. Nutr Clin Pract 2011; 26: 55–60. doi:10.1177/0884533610392380 http://www.ncbi.nlm.nih.gov/pubmed/21266698
79 Kawai K, Villamor E, Mugusi FM, et al. Predictors of change in nutritional and hemoglobin status among adults treated for tuberculosis in Tanzania. Int J Tuberc Lung Dis 2011; 15: 1380–9. doi:10.5588/ijtld.10.0784 http://www.ncbi.nlm.nih.gov/pubmed/22283899
80 de Jong BC, Adetifa I, Walther B, et al. Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an update. FEMS Immunol Med Microbiol 2010; 58: 102–5. doi:10.1111/j.1574-695X.2009.00628.x http://www.ncbi.nlm.nih.gov/pubmed/20002176
81 Podewils LJ, Holtz T, Riekstina V, et al. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients. Epidemiol Infect 2011; 139: 113–20. doi:10.1017/S0950268810000907 http://www.ncbi.nlm.nih.gov/pubmed/20429966
82 Warmelink I, van Altena R, ten Hacken N, et al. Nutritional status and vitamin D3 during antimicrobial treatment. Lancet 2011; 377: 1407–8. doi:10.1016/S0140-6736(11)60576-X http://www.ncbi.nlm.nih.gov/pubmed/21515160
83 Mupere E, Zalwango S, Chiunda A, et al. Body composition among HIV-seropositive and HIV-seronegative adult patients with pulmonary tuberculosis in Uganda. Ann Epidemiol 2010; 20: 210–6. doi:10.1016/j.annepidem.2009.11.001 http://www.ncbi.nlm.nih.gov/pubmed/20159491
84 Singla R, Sharma SK, Mohan A, et al. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity. Indian J Med Res 2010; 132: 81–6. http://www.ncbi.nlm.nih.gov/pubmed/20693595
85 Gambhir HS, Kaushik RM, Kaushik R, et al. Tobacco smoking-associated risk for tuberculosis: a case-control study. Int Health 2010; 2: 216–22. doi:10.1016/j.inhe.2010.07.001 http://www.ncbi.nlm.nih.gov/pubmed/24037702
86 Pakasi TA, Karyadi E, Suratih NMD, et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutr J 2010; 9: 41. doi:10.1186/1475-2891-9-41 http://www.ncbi.nlm.nih.gov/pubmed/20920186
87 Khoharo HK, Ansari S, Siddiqui AA. Standard antituberculosis drug induced hepatotoxicity: do the risk factors matter? J Liaquat Uni Med Health Sci 2010; 9: 84–7.
88 Kim J-S, Wilson JM, Lee S-R. Dietary implications on mechanisms of sarcopenia: roles of protein, amino acids and antioxidants. J Nutr Biochem 2010; 21: 1–13. doi:10.1016/j.jnutbio.2009.06.014 http://www.ncbi.nlm.nih.gov/pubmed/19800212
89 Ulasli SS, Ulubay G, Arslan NG, et al. Characteristics and outcomes of end-stage renal disease patients with active tuberculosis followed in intensive care units. Saudi J Kidney Dis Transpl 2009; 20: 254–9. http://www.ncbi.nlm.nih.gov/pubmed/19237814
90 Pakasi TA, Karyadi E, Dolmans WMV, et al. Malnutrition and socio-demographic factors associated with pulmonary tuberculosis in Timor and Rote Islands, Indonesia. Int J Tuberc Lung Dis 2009; 13: 755–9. http://www.ncbi.nlm.nih.gov/pubmed/19460253
91 Martins N, Morris P, Kelly PM. Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste. BMJ 2009; 339: b4248. doi:10.1136/bmj.b4248 http://www.ncbi.nlm.nih.gov/pubmed/19858174
92 Correia MITD, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr 2003; 22: 235–9. doi:10.1016/s0261-5614(02)00215-7 http://www.ncbi.nlm.nih.gov/pubmed/12765661
93 Gonzalez MC, Correia MITD, Heymsfield SB. A requiem for BMI in the clinical setting. Curr Opin Clin Nutr Metab Care 2017; 20: 314–21. doi:10.1097/MCO.0000000000000395 http://www.ncbi.nlm.nih.gov/pubmed/28768291
94 Jensen GL, Mirtallo J, Compher C, et al. Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International consensus guideline Committee. JPEN J Parenter Enteral Nutr 2010; 34: 156–9. doi:10.1177/0148607110361910 http://www.ncbi.nlm.nih.gov/pubmed/20375423
95 Cederholm T, Bosaeus I, Barazzoni R, et al. Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr 2015; 34: 335–40. doi:10.1016/j.clnu.2015.03.001 http://www.ncbi.nlm.nih.gov/pubmed/25799486
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Objectives
Malnutrition is associated with a twofold higher risk of dying in patients with tuberculosis (TB) and considered an important potentially reversible risk factor for failure of TB treatment. The construct of malnutrition has three domains: intake or uptake of nutrition; body composition and physical and cognitive function. The objectives of this systematic review are to identify malnutrition assessment methods, and to quantify how malnutrition assessment methods capture the international consensus definition for malnutrition, in patients with TB.
Design
Different assessment methods were identified. We determined the extent of capturing of the three domains of malnutrition, that is, intake or uptake of nutrition, body composition and physical and cognitive function.
Results
Seventeen malnutrition assessment methods were identified in 69 included studies. In 53/69 (77%) of studies, body mass index was used as the only malnutrition assessment method. Three out of 69 studies (4%) used a method that captured all three domains of malnutrition.
Conclusions
Our study focused on published articles. Implementation of new criteria takes time, which may take longer than the period covered by this review. Most patients with TB are assessed for only one aspect of the conceptual definition of malnutrition. The use of international consensus criteria is recommended to establish uniform diagnostics and treatment of malnutrition.
PROSPERO registration number
CRD42019122832.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Tuberculosis Center Beatrixoord, University of Groningen, University Medical Center Groningen, Haren, The Netherlands; Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, and Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
2 Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
3 Research Group Healthy Ageing, Allied Health Care and Nursing, Hanze University of Applied Sciences, Groningen, The Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
4 Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, and Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
5 Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
6 Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Tuberculosis Center Beatrixoord, University of Groningen, University Medical Center Groningen, Haren, The Netherlands
7 Department of Infection, Barts Health NHS Trust, London, UK; Blizard Institute, Queen Mary University of London, London, UK
8 Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
9 Faculty of Medicine and Health, University of Sydney, School of Pharmacy, Sydney, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia; Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia